Search
for
Sort by
Research 601–630 of 1000+
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl
- Ferulic acid promotes hair growth via estrogen receptor alpha activation in cultured human dermal papilla cells
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- 1323 The effects of 3-OH of kaempferol on interfollicular epidermal stem cell fate
- 1324 Impairment of hair-inducing capacity of 3D-cultured human dermal papilla cells by the ablation of STAT5
- 1327 Effect of ginsenoside Rd on dermal epidermal junction in fibroblast
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- New therapies for alopecia areata
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Aromatic plants as cosmeceuticals: benefits and applications for skin health